BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 22829014)

  • 1. Heterozygote FANCD2 mutations associated with childhood T Cell ALL and testicular seminoma.
    Smetsers S; Muter J; Bristow C; Patel L; Chandler K; Bonney D; Wynn RF; Whetton AD; Will AM; Rockx D; Joenje H; Strathdee G; Shanks J; Klopocki E; Gille JJ; Dorsman J; Meyer S
    Fam Cancer; 2012 Dec; 11(4):661-5. PubMed ID: 22829014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypomorphic mutations in the gene encoding a key Fanconi anemia protein, FANCD2, sustain a significant group of FA-D2 patients with severe phenotype.
    Kalb R; Neveling K; Hoehn H; Schneider H; Linka Y; Batish SD; Hunt C; Berwick M; Callen E; Surralles J; Casado JA; Bueren J; Dasi A; Soulier J; Gluckman E; Zwaan CM; van Spaendonk R; Pals G; de Winter JP; Joenje H; Grompe M; Auerbach AD; Hanenberg H; Schindler D
    Am J Hum Genet; 2007 May; 80(5):895-910. PubMed ID: 17436244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel Leu153Ser mutation of the Fanconi anemia FANCD2 gene is associated with severe chemotherapy toxicity in a pediatric T-cell acute lymphoblastic leukemia.
    Borriello A; Locasciulli A; Bianco AM; Criscuolo M; Conti V; Grammatico P; Cappellacci S; Zatterale A; Morgese F; Cucciolla V; Delia D; Della Ragione F; Savoia A
    Leukemia; 2007 Jan; 21(1):72-8. PubMed ID: 17096012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing the spectrum of germline variation in Fanconi anemia genes among patients with head and neck carcinoma before age 50.
    Chandrasekharappa SC; Chinn SB; Donovan FX; Chowdhury NI; Kamat A; Adeyemo AA; Thomas JW; Vemulapalli M; Hussey CS; Reid HH; Mullikin JC; Wei Q; Sturgis EM
    Cancer; 2017 Oct; 123(20):3943-3954. PubMed ID: 28678401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiplexed CRISPR/Cas9-mediated knockout of 19 Fanconi anemia pathway genes in zebrafish revealed their roles in growth, sexual development and fertility.
    Ramanagoudr-Bhojappa R; Carrington B; Ramaswami M; Bishop K; Robbins GM; Jones M; Harper U; Frederickson SC; Kimble DC; Sood R; Chandrasekharappa SC
    PLoS Genet; 2018 Dec; 14(12):e1007821. PubMed ID: 30540754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FANCD2, FANCJ and BRCA2 cooperate to promote replication fork recovery independently of the Fanconi Anemia core complex.
    Raghunandan M; Chaudhury I; Kelich SL; Hanenberg H; Sobeck A
    Cell Cycle; 2015; 14(3):342-53. PubMed ID: 25659033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coordination of the recruitment of the FANCD2 and PALB2 Fanconi anemia proteins by an ubiquitin signaling network.
    Bick G; Zhang F; Meetei AR; Andreassen PR
    Chromosoma; 2017 Jun; 126(3):417-430. PubMed ID: 27277787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recruitment of fanconi anemia and breast cancer proteins to DNA damage sites is differentially governed by replication.
    Shen X; Do H; Li Y; Chung WH; Tomasz M; de Winter JP; Xia B; Elledge SJ; Wang W; Li L
    Mol Cell; 2009 Sep; 35(5):716-23. PubMed ID: 19748364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fanconi anaemia and cancer: an intricate relationship.
    Nalepa G; Clapp DW
    Nat Rev Cancer; 2018 Mar; 18(3):168-185. PubMed ID: 29376519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fanconi-BRCA pathway mutations in childhood T-cell acute lymphoblastic leukemia.
    Pouliot GP; Degar J; Hinze L; Kochupurakkal B; Vo CD; Burns MA; Moreau L; Ganesa C; Roderick J; Peirs S; Menten B; Loh ML; Hunger SP; Silverman LB; Harris MH; Stevenson KE; Weinstock DM; Weng AP; Van Vlierberghe P; D'Andrea AD; Gutierrez A
    PLoS One; 2019; 14(11):e0221288. PubMed ID: 31721781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A requirement of FancL and FancD2 monoubiquitination in DNA repair.
    Seki S; Ohzeki M; Uchida A; Hirano S; Matsushita N; Kitao H; Oda T; Yamashita T; Kashihara N; Tsubahara A; Takata M; Ishiai M
    Genes Cells; 2007 Mar; 12(3):299-310. PubMed ID: 17352736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequency of heterozygous germline pathogenic variants in genes for Fanconi anemia in patients with non-BRCA1/BRCA2 breast cancer: a meta-analysis.
    Alter BP; Best AF
    Breast Cancer Res Treat; 2020 Jul; 182(2):465-476. PubMed ID: 32488392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct roles of FANCO/RAD51C protein in DNA damage signaling and repair: implications for Fanconi anemia and breast cancer susceptibility.
    Somyajit K; Subramanya S; Nagaraju G
    J Biol Chem; 2012 Jan; 287(5):3366-80. PubMed ID: 22167183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene-specific selection against experimental fanconi anemia gene inactivation in human cancer.
    Gallmeier E; Hucl T; Calhoun ES; Cunningham SC; Bunz F; Brody JR; Kern SE
    Cancer Biol Ther; 2007 May; 6(5):654-60. PubMed ID: 17387268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genotype-cancer association in patients with Fanconi anemia due to pathogenic variants in FANCD1 (BRCA2) or FANCN (PALB2).
    McReynolds LJ; Biswas K; Giri N; Sharan SK; Alter BP
    Cancer Genet; 2021 Nov; 258-259():101-109. PubMed ID: 34687993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Function of the Fanconi anemia pathway in Fanconi anemia complementation group F and D1 cells.
    Siddique MA; Nakanishi K; Taniguchi T; Grompe M; D'Andrea AD
    Exp Hematol; 2001 Dec; 29(12):1448-55. PubMed ID: 11750104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FANCJ protein is important for the stability of FANCD2/FANCI proteins and protects them from proteasome and caspase-3 dependent degradation.
    Clark DW; Tripathi K; Dorsman JC; Palle K
    Oncotarget; 2015 Oct; 6(30):28816-32. PubMed ID: 26336824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Fanconi anemia: genes and function(s) revisited].
    Papadopoulo D; Moustacchi E
    Med Sci (Paris); 2005; 21(8-9):730-6. PubMed ID: 16115458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FANCI is a second monoubiquitinated member of the Fanconi anemia pathway.
    Sims AE; Spiteri E; Sims RJ; Arita AG; Lach FP; Landers T; Wurm M; Freund M; Neveling K; Hanenberg H; Auerbach AD; Huang TT
    Nat Struct Mol Biol; 2007 Jun; 14(6):564-7. PubMed ID: 17460694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone Marrow Mesenchymal Stem Cells Carrying FANCD2 Mutation Differ from the Other Fanconi Anemia Complementation Groups in Terms of TGF-β1 Production.
    Cagnan I; Gunel-Ozcan A; Aerts-Kaya F; Ameziane N; Kuskonmaz B; Dorsman J; Gumruk F; Uckan D
    Stem Cell Rev Rep; 2018 Jun; 14(3):425-437. PubMed ID: 29247345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.